RC
CLMT icon

Rangeley Capital’s Calumet Specialty Products CLMT Stock Holding History

Rangeley Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,000
Closed -$76.1K – 80
2025
Q1 		$76.1K Buy
6,000
+1,000
+20% +$15.7K 0.08% 71
2024
Q4 		$110K Buy
+5,000
New +$105K 0.1% 74

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rangeley Capital's CLMT Position: Q1 2026 in Review

Rangeley Capital reduced its Calumet Specialty Products (CLMT) stake by 80% in Q1 2026, selling an estimated $5.34M and leaving 53,000 shares worth $1.9M. The position accounts for 1.85% of the portfolio, ranked #17.

Rangeley Capital first reported a position in CLMT in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.8M in Q4 2024. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Rangeley Capital held 53,000 shares of Calumet Specialty Products worth $1.9M as of Q1 2026.
  • Rangeley Capital sold 206,300 Calumet Specialty Products shares in Q1 2026, an estimated $5.34M.
  • Calumet Specialty Products made up 1.85% of Rangeley Capital's portfolio in Q1 2026, its #17 holding.
  • Rangeley Capital first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 6 quarters since.
  • Rangeley Capital's Calumet Specialty Products position peaked at $11.8M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.